Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386650785> ?p ?o ?g. }
- W4386650785 abstract "Abstract Background Cancer cells are characterized by changes in cell cytoskeletal architecture and stiffness. Despite advances in understanding the molecular mechanisms of musculoskeletal cancers, the corresponding cellular mechanical properties remain largely unexplored. The aim of this study was to investigate the changes in cellular stiffness and the associated cytoskeleton configuration alterations in various musculoskeletal cancer cells. Methods Cell lines from five main sarcoma types of the musculoskeletal system (chondrosarcoma, osteosarcoma, Ewing sarcoma, fibrosarcoma and rhabdomyosarcoma) as well as their healthy cell counterparts (chondrocytes, osteoblasts, mesenchymal stem cells, fibroblasts, skeletal muscle cells) were subjected to cell stiffness measurements via atomic force microscopy (AFM). Biochemical and structural changes of the cytoskeleton (F-actin, β-tubulin and actin-related protein 2/3) were assessed by means of fluorescence labelling, ELISA and qPCR. Results While AFM stiffness measurements showed that the majority of cancer cells (osteosarcoma, Ewing sarcoma, fibrosarcoma and rhabdomyosarcoma) were significantly less stiff than their corresponding non-malignant counterparts (p < 0.001), the chondrosarcoma cells were significant stiffer than the chondrocytes (p < 0.001). Microscopically, the distribution of F-actin differed between malignant entities and healthy counterparts: the organisation in well aligned stress fibers was disrupted in cancer cell lines and the proteins was mainly concentrated at the periphery of the cell, whereas β-tubulin had a predominantly perinuclear localization. While the F-actin content was lower in cancer cells, particularly Ewing sarcoma (p = 0.018) and Fibrosarcoma (p = 0.023), this effect was even more pronounced in the case of β-tubulin for all cancer-healthy cell duos. Interestingly, chondrosarcoma cells were characterized by a significant upregulation of β-tubulin gene expression (p = 0.005) and protein amount (p = 0.032). Conclusion Modifications in cellular stiffness, along with structural and compositional cytoskeleton rearrangement, constitute typical features of sarcomas cells, when compared to their healthy counterpart. Notably, whereas a decrease in stiffness is typically a feature of malignant entities, chondrosarcoma cells were stiffer than chondrocytes, with chondrosarcoma cells exhibiting a significantly upregulated β-tubulin expression. Each Sarcoma entity may have his own cellular-stiffness and cytoskeleton organisation/composition fingerprint, which in turn may be exploited for diagnostic or therapeutic purposes." @default.
- W4386650785 created "2023-09-13" @default.
- W4386650785 creator A5016032676 @default.
- W4386650785 creator A5016738016 @default.
- W4386650785 creator A5027513695 @default.
- W4386650785 creator A5032449497 @default.
- W4386650785 creator A5033147970 @default.
- W4386650785 creator A5080611953 @default.
- W4386650785 creator A5080636101 @default.
- W4386650785 date "2023-09-12" @default.
- W4386650785 modified "2023-10-14" @default.
- W4386650785 title "An exploratory study of cell stiffness as a mechanical label-free biomarker across multiple musculoskeletal sarcoma cells" @default.
- W4386650785 cites W1039497556 @default.
- W4386650785 cites W1665195633 @default.
- W4386650785 cites W1840209374 @default.
- W4386650785 cites W1943756471 @default.
- W4386650785 cites W1971787026 @default.
- W4386650785 cites W1988011959 @default.
- W4386650785 cites W1989095124 @default.
- W4386650785 cites W1994109845 @default.
- W4386650785 cites W1996152000 @default.
- W4386650785 cites W2008260566 @default.
- W4386650785 cites W2016983464 @default.
- W4386650785 cites W2058738554 @default.
- W4386650785 cites W2060301180 @default.
- W4386650785 cites W2074328351 @default.
- W4386650785 cites W2076692938 @default.
- W4386650785 cites W2092412094 @default.
- W4386650785 cites W2092994838 @default.
- W4386650785 cites W2107277218 @default.
- W4386650785 cites W2111655844 @default.
- W4386650785 cites W2116413963 @default.
- W4386650785 cites W2127293878 @default.
- W4386650785 cites W2135283449 @default.
- W4386650785 cites W2139502587 @default.
- W4386650785 cites W2140274087 @default.
- W4386650785 cites W2149374899 @default.
- W4386650785 cites W2154154147 @default.
- W4386650785 cites W2159835158 @default.
- W4386650785 cites W2163802608 @default.
- W4386650785 cites W2192080449 @default.
- W4386650785 cites W2265505631 @default.
- W4386650785 cites W2277944030 @default.
- W4386650785 cites W2287975101 @default.
- W4386650785 cites W2295993263 @default.
- W4386650785 cites W2417406783 @default.
- W4386650785 cites W2586629973 @default.
- W4386650785 cites W2729953575 @default.
- W4386650785 cites W2744978288 @default.
- W4386650785 cites W2754998223 @default.
- W4386650785 cites W2774074031 @default.
- W4386650785 cites W2788603723 @default.
- W4386650785 cites W2793676899 @default.
- W4386650785 cites W2898316129 @default.
- W4386650785 cites W2930640644 @default.
- W4386650785 cites W3014799460 @default.
- W4386650785 cites W3022732381 @default.
- W4386650785 cites W3045120309 @default.
- W4386650785 cites W3049768544 @default.
- W4386650785 cites W3091805122 @default.
- W4386650785 cites W3093621895 @default.
- W4386650785 cites W3104606491 @default.
- W4386650785 cites W3109961441 @default.
- W4386650785 cites W3137737231 @default.
- W4386650785 cites W3154382066 @default.
- W4386650785 cites W3174167446 @default.
- W4386650785 cites W3216191044 @default.
- W4386650785 cites W3217766114 @default.
- W4386650785 cites W387778353 @default.
- W4386650785 cites W4316670331 @default.
- W4386650785 cites W772589830 @default.
- W4386650785 doi "https://doi.org/10.1186/s12885-023-11375-3" @default.
- W4386650785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37700272" @default.
- W4386650785 hasPublicationYear "2023" @default.
- W4386650785 type Work @default.
- W4386650785 citedByCount "0" @default.
- W4386650785 crossrefType "journal-article" @default.
- W4386650785 hasAuthorship W4386650785A5016032676 @default.
- W4386650785 hasAuthorship W4386650785A5016738016 @default.
- W4386650785 hasAuthorship W4386650785A5027513695 @default.
- W4386650785 hasAuthorship W4386650785A5032449497 @default.
- W4386650785 hasAuthorship W4386650785A5033147970 @default.
- W4386650785 hasAuthorship W4386650785A5080611953 @default.
- W4386650785 hasAuthorship W4386650785A5080636101 @default.
- W4386650785 hasBestOaLocation W43866507851 @default.
- W4386650785 hasConcept C121608353 @default.
- W4386650785 hasConcept C125705527 @default.
- W4386650785 hasConcept C126322002 @default.
- W4386650785 hasConcept C142669718 @default.
- W4386650785 hasConcept C142724271 @default.
- W4386650785 hasConcept C1491633281 @default.
- W4386650785 hasConcept C185592680 @default.
- W4386650785 hasConcept C198826908 @default.
- W4386650785 hasConcept C2776302905 @default.
- W4386650785 hasConcept C2776495794 @default.
- W4386650785 hasConcept C2778256501 @default.
- W4386650785 hasConcept C2780844630 @default.
- W4386650785 hasConcept C502942594 @default.
- W4386650785 hasConcept C55493867 @default.
- W4386650785 hasConcept C71924100 @default.